[CHRS] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -16.61%
YoY- 162.67%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 45,352 73,371 110,419 123,856 0 0 844 94.19%
PBT -58,870 -45,725 10,760 41,271 -62,596 -49,069 -75,944 -4.15%
Tax 7,377 5,793 1,052 2,044 70 114 428 60.68%
NP -66,247 -45,725 9,708 39,227 -62,596 -49,067 -75,921 -2.24%
Tax Rate - - -9.78% -4.95% - - - -
Total Cost 111,599 119,096 100,711 84,629 62,596 49,067 76,765 6.43%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -146.07 -62.32 8.79 31.67 0.00 0.00 -8,995.38 -49.66%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.85 -0.60 0.13 0.56 -0.92 -0.84 -1.71 -10.99%
EPS Diluted -0.85 -0.60 0.12 0.53 -0.92 -0.84 -1.71 -10.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.